Her Excellency Marie Bashir Sees Bridges to Peace at Hadassah's Hospitals
"You are in the best place in the world, where everyone cares for your son," Her Excellency, Professor and Governor of New South Wales Marie Bashir said. She was speaking to the mother of Baby Ali—in Arabic—during her recent visit to the Hadassah Medical Organization. The mother responded, “I know.”
Hadassah Researcher Honored with Prestigious Prize for Blood Discovery
Principal Investigator Dr. Rinat Abramovitch of the Hadassah Medical Organization’s Goldyne Savad Institute of Gene Therapy, has been awarded a grant from the European Society of Anesthesiology (ESA) for her work regarding the beneficial effect of using fresh blood for transfusions in surgery patients.
IVF Babies: A Gift of Israel and Hadassah to Its People
Unlike countries where couples spend their entire life savings trying to conceive a child with the help of expensive medical intervention such as in vitro fertilization (IVF), Israel provides free IVF until a woman has two babies or reaches age 45. Israel has the highest per capita use of IVF in the world.
Healing Garden at Hadassah's Hospitals Dedicated to Smorgon Family
The Jack and Robert Smorgon Families' Foundation Healing and Environmental Garden was dedicated at Hadassah University Hospital, Mount Scopus on June 22, in the presence of Jack Smorgon, family members, the Director General of the Ministry of Health Prof.
International Symposium on Pancreatic Disease Headed Up by Hadassah Specialist
Earlier this month, Jerusalem hosted an international symposium dealing with inherited diseases of the pancreas. The symposium was organized by Prof. Michael Wilschanski, Director of Hadassah’s Pediatric Gastroenterology Unit, along with Prof. Markus M. Lerch of Greifswald University Hospital, Germany, and Prof. David C. Whitcomb of the University of Pittsburgh, PA.
BioLineRx to Commence Phase 1 Stem Cell Trial at Hadassah Medical Organization
BioLineRx Ltd. has received approval from the Israeli Ministry of Health to commence a Phase 1 trial for BL-8040, a novel treatment for mobilizing stem cells from the bone marrow for treating acute myeloid leukemia, as well as other hematological malignancies. The study is expected to begin during the third quarter of 2014 at the Hadassah Medical Organization.
Hadassah’s Prof. Eitan Kerem Receives European Cystic Fibrosis Society 2014 Prize
Prof. Eitan Kerem, world-renowned cystic fibrosis specialist and head of the Hadassah Medical Organization’s Division of Pediatrics, has been awarded the European Cystic Fibrosis Society (ECFS)’s 2014 prize for his outstanding work in CF.
Hadassah's School Awarded 2014 National Education Award
Hadassah’s Experimental School (HES), which provides hospitalized children of all ages and backgrounds with an education in its unique hospital-based school, has been honored with Israel’s National Education Award by the Ministry of Education.
International “No Smoking Day 2014” at Hadassah's Hospitals
In cooperation with the World Health Organization (WHO)’s “No Smoking Day 2014,” the Hadassah Medical Organization’s employees and visitors received up-to-date information about the negative health effects of smoking as well as advice on therapeutic interventions to help them delete this habit from their lives.
Mid-Workout, Hadassah Doctor Sprints to Save a Life
One recent Friday afternoon, Dr. Haim Danenberg, Director of Interventional Cardiology at the Hadassah Medical Organization, was out for a run, cell phone strapped to his forearm, as is his tradition. When he received the call that he was needed for emergency heart surgery, he immediately came to Hadassah’s Catheterization Laboratory to greet Michael Kosofsky, who just suffered a heart attack.
Going Local: Heads of Hadassah’s ERs Forge Bond with Community Pediatricians
To bridge the gaps between pediatric emergency room (ER) and community medical care, heads of Hadassah’s emergency services reached out to neighborhood physicians and medics to share information and initiate a dialogue.
Hadassah’s Innovative Cardiac Protocol Saves Man’s Life
An appreciative heart attack victim recounts the innovative protocol that the Hadassah Medical Organization put into action to ensure his survival and quality of life. In his letter, he also highlights the groundbreaking procedures—like one for dissolving blood clots--that Hadassah pioneered, saving thousands of lives.
New Trial Data out of Hadassah Hospitals Show Promise for Stem Cell Treatment of ALS
Interim results from Israel’s BrainStorm Cell Therapeutics’ Phase IIa stem cell clinical trial, conducted at the Hadassah Medical Center for the treatment of amyotrophic lateral sclerosis (ALS), are promising.
Growing Heart Healthy Kids in the Heart of East Jerusalem
Heart health is a major focus for Hadassah in both the U.S. and Israel. In the U.S., thousands of women and girls are participating in walks, lectures and health fairs under the aegis of Every Beat Counts: Hadassah’s Heart Health Program™. In Israel, Hadassah Medical Organization’s Linda Joy Pollin Cardiovascular Wellness Center for Women—part of its Heart Health Institute—is taking the heart health message to children, mothers and teachers in Palestinian schools in East Jerusalem.
During his trip to Jerusalem, Pope Francis landed at the helipad at the Hadassah Hospital on Mount Scopus. He was welcomed by Dr. Osnat Levtzion-Korach, the Director of the Hadassah's Hospital on Mount Scopus, and a choir of Israeli children sang for him.
Prof. Alexander Margulis: Hadassah Pediatric Plastic Surgeon and Israel Navy Seal
Meet Prof. Alex Margulis: As his “day job,” Prof. Alex Margulis heads the Hadassah Medical Center’s Pediatric Plastic Surgery and Craniofacial Unit, where children born with birth defects or injured in terrorist attacks are given a new lease on life.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>